This federal contract award, valued at $2,084.70, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of RIFAMPIN 300 MG CAPSULE 60S, with an ultimate completion date of November 1, 2024. The contract type is a Delivery Order, with a Firm Fixed Price pricing type. This award is not designated with any set-aside requirements, indicating open competition. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The company also maintains a separate IDC with the Department of Justice Federal Bureau of Investigation, valued at $750,000 through May 2024, which covers similar medical products and prescription drugs.
Generated 1/30/25, 9:03 AM